GRK2: A Novel Cell-Specific Regulator of Severity and Duration of Inflammatory Pain
Niels Eijkelkamp(Utrecht University), Annemieke Kavelaars(The University of Texas MD Anderson Cancer Center)
Cited by 106
Related Papers
Complex I inhibitor of oxidative phosphorylation in advanced solid tumors and acute myeloid leukemia: phase I trials
|Nature Medicine|2023|372
Balancing GRK2 and EPAC1 levels prevents and relieves chronic pain
|Journal of Clinical Investigation|2013|97
CD8+ T cell–derived IL-13 increases macrophage IL-10 to resolve neuropathic pain
|JCI Insight|2022|93